{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:38:20Z","timestamp":1789799900428,"version":"4.0.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006752","name":"Universidade do Porto","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006752","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>Benign prostatic hyperplasia (BPH) is a highly prevalent urological condition in aging men, contributing to lower urinary tract symptoms (LUTS) and reducing the quality of life. The increasing burden of BPH underscores the need for preventive strategies targeting modifiable risk factors. This review examines the evidence on the association between physical activity (PA), exercise, and BPH risk, aiming to determine whether these two forms of activity exert different effects on BPH pathogenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>A literature search was conducted in multiple databases to identify human studies evaluating the association between PA or exercise and the risk of developing BPH and\/or LUTS. A total of 19 studies were included: 17 observational studies, one meta-analysis, and one two-sample Mendelian randomization study. Among the six studies evaluating exercise, four reported a protective effect against BPH development, while two found no significant association. Moderate-intensity exercise appeared to confer greater protection than high-intensity exercise. Of the 14 studies assessing PA, seven reported a protective effect, with most indicating that high-intensity PA provided the greatest benefit. Two studies yielded mixed results, while five found no significant association between PA and BPH risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Although moderate-intensity exercise and moderate-to-high PA appear to reduce BPH risk, evidence remains inconsistent. Future research should prioritize randomized controlled trials with standardized protocols, clearly defined outcomes, and objective assessment of dose\u2013response effects to elucidate underlying mechanisms. Such approaches are critical to clarify the role of exercise and PA in BPH prevention and to inform clinical and public health recommendations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11934-026-01346-z","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T03:56:06Z","timestamp":1784606166000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exercise and Physical Activity as Modifiable Risk Factors for Benign Prostatic Hyperplasia: An Update"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5182-9429","authenticated-orcid":false,"given":"Frederico","family":"Branco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3724-1417","authenticated-orcid":false,"given":"S\u00edlvia","family":"Rocha-Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8142-5382","authenticated-orcid":false,"given":"Mar\u00eda J.","family":"Ribal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9785-857X","authenticated-orcid":false,"given":"Ricardo","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"issue":"3","key":"1346_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ajur.2017.06.004","volume":"4","author":"KB Lim","year":"2017","unstructured":"Lim KB. Epidemiology of clinical benign prostatic hyperplasia. Asian J Urol. 2017;4(3):148\u201351. https:\/\/doi.org\/10.1016\/j.ajur.2017.06.004.","journal-title":"Asian J Urol"},{"issue":"2","key":"1346_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.pop.2019.02.003","volume":"46","author":"RC Langan","year":"2019","unstructured":"Langan RC. Benign Prostatic Hyperplasia. Prim Care Clin Off Pract. 2019;46(2):223\u201332. https:\/\/doi.org\/10.1016\/j.pop.2019.02.003.","journal-title":"Prim Care Clin Off Pract"},{"issue":"S3","key":"1346_CR3","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1038\/ijir.2008.55","volume":"20","author":"CG Roehrborn","year":"2008","unstructured":"Roehrborn CG. Pathology of benign prostatic hyperplasia. Int J Impot Res. 2008;20(S3):S11-8. https:\/\/doi.org\/10.1038\/ijir.2008.55.","journal-title":"Int J Impot Res"},{"key":"1346_CR4","unstructured":"Ng M, Leslie S, Baradhi K. Benign Prostatic Hyperplasia. [Updated 2024 Oct 20]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK558920\/"},{"issue":"3","key":"1346_CR5","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S0022-5347(17)49698-4","volume":"132","author":"SJ Berry","year":"1984","unstructured":"Berry SJ, Coffey DS, Walsh PC, Ewing LL. The Development of Human Benign Prostatic Hyperplasia with Age. J Urol. 1984;132(3):474\u20139. https:\/\/doi.org\/10.1016\/S0022-5347(17)49698-4.","journal-title":"J Urol"},{"issue":"1554","key":"1346_CR6","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1098\/rstb.2010.0133","volume":"365","author":"W Lutz","year":"2010","unstructured":"Lutz W, Kc S. Dimensions of global population projections: what do we know about future population trends and structures? Philos Trans R Soc B Biol Sci. 2010;365(1554):2779\u201391. https:\/\/doi.org\/10.1098\/rstb.2010.0133.","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"1346_CR7","unstructured":"He W, Goodkind D, Kowal P, An Aging W. 2015 Census Bureau. Accessed February 1st 2025. Available at: https:\/\/www.census.gov\/library\/publications\/2016\/demo\/P95-16-1.html"},{"issue":"9","key":"1346_CR8","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/oxfordjournals.aje.a117745","volume":"142","author":"RO Roberts","year":"1995","unstructured":"Roberts RO, Rhodes T, Panser LA, Girman CJ, Chute CG, Guess HA, et al. Association between Family History of Benign Prostatic Hyperplasia and Urinary Symptoms: Results of a Population-based Study. Am J Epidemiol. 1995;142(9):965\u201373. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a117745.","journal-title":"Am J Epidemiol"},{"issue":"6","key":"1346_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.fjs.2014.10.001","volume":"47","author":"SH Lu","year":"2014","unstructured":"Lu SH, Chen CS. Natural history and epidemiology of benign prostatic hyperplasia. Formos J Surg. 2014;47(6):207\u201310. https:\/\/doi.org\/10.1016\/j.fjs.2014.10.001.","journal-title":"Formos J Surg"},{"issue":"4\u20135","key":"1346_CR10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.diff.2011.04.006","volume":"82","author":"TM Nicholson","year":"2011","unstructured":"Nicholson TM, Ricke WA. Androgens and estrogens in benign prostatic hyperplasia: past, present and future. Differentiation. 2011;82(4\u20135):184\u201399. https:\/\/doi.org\/10.1016\/j.diff.2011.04.006.","journal-title":"Differentiation"},{"issue":"2","key":"1346_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.afju.2018.01.005","volume":"24","author":"A Ajayi","year":"2018","unstructured":"Ajayi A, Abraham K. Understanding the role of estrogen in the development of benign prostatic hyperplasia. Afr J Urol. 2018;24(2):93\u20137. https:\/\/doi.org\/10.1016\/j.afju.2018.01.005.","journal-title":"Afr J Urol"},{"issue":"3","key":"1346_CR12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ajur.2019.10.003","volume":"7","author":"RE Vickman","year":"2020","unstructured":"Vickman RE, Franco OE, Moline DC, Vander Griend DJ, Thumbikat P, Hayward SW. The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review. Asian J Urol. 2020;7(3):191\u2013202. https:\/\/doi.org\/10.1016\/j.ajur.2019.10.003.","journal-title":"Asian J Urol"},{"issue":"4","key":"1346_CR13","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.juro.2006.11.065","volume":"177","author":"AR Kristal","year":"2007","unstructured":"Kristal AR, Arnold KB, Schenk JM, Neuhouser ML, Weiss N, Goodman P, et al. Race\/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial. J Urol. 2007;177(4):1395\u2013400. https:\/\/doi.org\/10.1016\/j.juro.2006.11.065.","journal-title":"J Urol"},{"issue":"5","key":"1346_CR14","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1016\/j.juro.2008.07.059","volume":"180","author":"JH Fowke","year":"2008","unstructured":"Fowke JH, Murff HJ, Signorello LB, Lund L, Blot WJ. Race and socioeconomic status are independently associated with benign prostatic hyperplasia. J Urol. 2008;180(5):2091\u20136. https:\/\/doi.org\/10.1016\/j.juro.2008.07.059.","journal-title":"J Urol"},{"issue":"4","key":"1346_CR15","first-page":"1","volume":"6","author":"ED Yeboah","year":"2016","unstructured":"Yeboah ED, Prevalence of benign prostatic hyperplasia and prostate cancer in africans, and africans in the diaspora. J West Afr Coll Surg. 2016;6(4):1\u201330. PubMed PMID: 29181363; PubMed Central PMCID: PMC5667727.","journal-title":"J West Afr Coll Surg"},{"issue":"11","key":"1346_CR16","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1093\/oxfordjournals.aje.a117206","volume":"140","author":"E Giovannucci","year":"1994","unstructured":"Giovannucci E, Rimm EB, Chute CG, Kawachi I, Colditz GA, Stampfer MJ, et al. Obesity and Benign Prostatic Hyperplasia. Am J Epidemiol. 1994;140(11):989\u20131002. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a117206.","journal-title":"Am J Epidemiol"},{"issue":"6","key":"1346_CR17","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1016\/j.juro.2009.07.086","volume":"182","author":"JK Parsons","year":"2009","unstructured":"Parsons JK, Sarma AV, McVary K, Wei JT. Obesity and Benign Prostatic Hyperplasia: Clinical Connections, Emerging Etiological Paradigms and Future Directions. Symp Urol Complicat Obes Diabetes. 2009;182(6):S27\u201331. https:\/\/doi.org\/10.1016\/j.juro.2009.07.086.","journal-title":"Symp Urol Complicat Obes Diabetes"},{"issue":"3","key":"1346_CR18","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/pcan.2011.65","volume":"15","author":"S Wang","year":"2012","unstructured":"Wang S, Mao Q, Lin Y, Wu J, Wang X, Zheng X, et al. Body mass index and risk of BPH: a meta-analysis. Prostate Cancer Prostatic Dis. 2012;15(3):265\u201372. https:\/\/doi.org\/10.1038\/pcan.2011.65.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"1346_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03722-y","volume":"20","author":"YB Wang","year":"2022","unstructured":"Wang YB, Yang L, Deng YQ, Yan SY, Luo LS, Chen P, et al. Causal relationship between obesity, lifestyle factors and risk of benign prostatic hyperplasia: a univariable and multivariable Mendelian randomization study. J Transl Med. 2022;20(1):495. https:\/\/doi.org\/10.1186\/s12967-022-03722-y.","journal-title":"J Transl Med"},{"issue":"1","key":"1346_CR20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jomh.2010.09.231","volume":"8","author":"R Tewari","year":"2011","unstructured":"Tewari R, Prabhat P, Natu SM, Dalela D, Goel A, Goel MM, et al. Association of benign prostatic hyperplasia (BPH) with the metabolic syndrome (MS) and its components \u2013 \u2018a growing dilemma\u2019. J Mens Health. 2011;8(1):66\u201371. https:\/\/doi.org\/10.1016\/j.jomh.2010.09.231.","journal-title":"J Mens Health"},{"issue":"1","key":"1346_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.urology.2011.08.065","volume":"79","author":"AV Sarma","year":"2012","unstructured":"Sarma AV, St. Sauver JL, Hollingsworth JM, Jacobson DJ, McGree ME, Dunn RL, et al. Diabetes treatment and progression of benign prostatic hyperplasia in community-dwelling Black and White men. Urology. 2012;79(1):102\u20138. https:\/\/doi.org\/10.1016\/j.urology.2011.08.065.","journal-title":"Urology"},{"issue":"12","key":"1346_CR22","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s11934-014-0462-x","volume":"15","author":"BN Breyer","year":"2014","unstructured":"Breyer BN, Sarma AV. Hyperglycemia and Insulin Resistance and the Risk of BPH\/LUTS: an Update of Recent Literature. Curr Urol Rep. 2014;15(12):462. https:\/\/doi.org\/10.1007\/s11934-014-0462-x.","journal-title":"Curr Urol Rep"},{"key":"1346_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.741748","volume":"12","author":"C Xin","year":"2022","unstructured":"Xin C, Fan H, Xie J, Hu J, Sun X, Liu Q. Impact of diabetes mellitus on lower urinary tract symptoms in benign prostatic hyperplasia patients: a meta-analysis. Front Endocrinol. 2022;12:741748. https:\/\/doi.org\/10.3389\/fendo.2021.741748.","journal-title":"Front Endocrinol"},{"issue":"8","key":"1346_CR24","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1093\/aje\/kwm389","volume":"167","author":"AR Kristal","year":"2008","unstructured":"Kristal AR, Arnold KB, Schenk JM, Neuhouser ML, Goodman P, Penson DF, et al. Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial. Am J Epidemiol. 2008;167(8):925\u201334. https:\/\/doi.org\/10.1093\/aje\/kwm389.","journal-title":"Am J Epidemiol"},{"issue":"4","key":"1346_CR25","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s11884-010-0067-2","volume":"5","author":"JK Parsons","year":"2010","unstructured":"Parsons JK. Benign prostatic hyperplasia and male lower urinary tract symptoms: epidemiology and risk factors. Curr Bladder Dysfunct Rep. 2010;5(4):212\u20138. https:\/\/doi.org\/10.1007\/s11884-010-0067-2.","journal-title":"Curr Bladder Dysfunct Rep"},{"issue":"6","key":"1346_CR26","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.eururo.2008.02.019","volume":"53","author":"JK Parsons","year":"2008","unstructured":"Parsons JK, Kashefi C. Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms. Eur Urol. 2008;53(6):1228\u201335. https:\/\/doi.org\/10.1016\/j.eururo.2008.02.019.","journal-title":"Eur Urol"},{"issue":"4","key":"1346_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3810\/psm.2009.12.1745","volume":"37","author":"J Sea","year":"2009","unstructured":"Sea J, Poon KS, McVary KT. Review of Exercise and the Risk of Benign Prostatic Hyperplasia. Phys Sportsmed. 2009;37(4):75\u201383. https:\/\/doi.org\/10.3810\/psm.2009.12.1745.","journal-title":"Phys Sportsmed"},{"key":"1346_CR28","doi-asserted-by":"publisher","unstructured":"Shephard RJ. Benign prostate hyperplasia: a further reason to recommend regular physical activity? Health Fit J Can. 2016;38\u201355. https:\/\/doi.org\/10.14288\/HFJC.V9I2.206.","DOI":"10.14288\/HFJC.V9I2.206"},{"issue":"1","key":"1346_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/nuf.12296","volume":"54","author":"NA Dasso","year":"2019","unstructured":"Dasso NA. How is exercise different from physical activity? A concept analysis: DASSO. Nurs Forum (Auckl). 2019;54(1):45\u201352. https:\/\/doi.org\/10.1111\/nuf.12296.","journal-title":"Nurs Forum (Auckl)"},{"issue":"20","key":"1346_CR30","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.eursup.2006.08.008","volume":"5","author":"M Emberton","year":"2006","unstructured":"Emberton M, Martorana G. BPH: social impact and patient\u2019s perspective. Eur Urol Suppl. 2006;5(20):991\u20136. https:\/\/doi.org\/10.1016\/j.eursup.2006.08.008.","journal-title":"Eur Urol Suppl"},{"issue":"11","key":"1346_CR31","doi-asserted-by":"publisher","first-page":"e754","DOI":"10.1016\/S2666-7568(22)00213-6","volume":"3","author":"AF Awedew","year":"2022","unstructured":"Awedew AF, Han H, Abbasi B, Abbasi-Kangevari M, Ahmed MB, Almidani O, et al. The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Healthy Longev. 2022;3(11):e754\u201376. https:\/\/doi.org\/10.1016\/S2666-7568(22)00213-6.","journal-title":"Lancet Healthy Longev"},{"issue":"3","key":"1346_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5213\/inj.2014.18.3.155","volume":"18","author":"HW Lee","year":"2014","unstructured":"Lee HW, Kim SA, Nam JW, Kim MK, Choi BY, Moon HS. The Study About Physical Activity for Subjects With Prevention of Benign Prostate Hyperplasia. Int Neurourol J. 2014;18(3):155. https:\/\/doi.org\/10.5213\/inj.2014.18.3.155.","journal-title":"Int Neurourol J"},{"issue":"1","key":"1346_CR33","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/pros.2990260109","volume":"26","author":"PH Gann","year":"1995","unstructured":"Gann PH, Hennekens CH, Grodstein F, Stampfer MJ, Longcope C, Verhoek-Oftedahl W. A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia. The Prostate. 1995;26(1):40\u20139. https:\/\/doi.org\/10.1002\/pros.2990260109.","journal-title":"The Prostate"},{"issue":"1","key":"1346_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000089729","volume":"76","author":"J Hong","year":"2006","unstructured":"Hong J, Kwon S, Yoon H, Lee H, Lee B, Kim HH, et al. Risk factors for benign prostatic hyperplasia in South Korean men. Urol Int. 2006;76(1):11\u20139. https:\/\/doi.org\/10.1159\/000089729.","journal-title":"Urol Int"},{"issue":"4","key":"1346_CR35","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.prnil.2022.06.004","volume":"10","author":"Y Nagakura","year":"2022","unstructured":"Nagakura Y, Hayashi M, Kajioka S. Lifestyle habits to prevent the development of benign prostatic hyperplasia: Analysis of Japanese nationwide datasets. Prostate Int. 2022;10(4):200\u20136. https:\/\/doi.org\/10.1016\/j.prnil.2022.06.004.","journal-title":"Prostate Int"},{"issue":"10","key":"1346_CR36","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1249\/MSS.0b013e31817b8eba","volume":"40","author":"PT Williams","year":"2008","unstructured":"Williams PT. Effects of Running Distance and Performance on Incident Benign Prostatic Hyperplasia. Med Sci Sports Exerc. 2008;40(10):1733\u20139. https:\/\/doi.org\/10.1249\/MSS.0b013e31817b8eba.","journal-title":"Med Sci Sports Exerc"},{"key":"1346_CR37","doi-asserted-by":"publisher","unstructured":"Jia F, Wei Z, Kong X, Mao Y, Yang Y. Causal Associations Between Lifestyle Habits and Risk of Benign Prostatic Hyperplasia: A Two-Sample Mendelian Randomization Study. Magaziner J, editor. J Gerontol Ser A. 2024;79(1):glad187. https:\/\/doi.org\/10.1093\/gerona\/glad187","DOI":"10.1093\/gerona\/glad187"},{"issue":"2","key":"1346_CR38","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/ije\/30.2.341","volume":"30","author":"JV Lacey","year":"2001","unstructured":"Lacey JV, Deng J, Dosemeci M, Gao YT, Mostofi F, Sesterhenn IA, et al. Prostate cancer, benign prostatic hyperplasia and physical activity in Shanghai, China. Int J Epidemiol. 2001;30(2):341\u20139. https:\/\/doi.org\/10.1093\/ije\/30.2.341.","journal-title":"Int J Epidemiol"},{"issue":"10","key":"1346_CR39","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/aje\/kwg051","volume":"157","author":"MA Joseph","year":"2003","unstructured":"Joseph MA. Risk factors for lower urinary tract symptoms in a population-based sample of African-American men. Am J Epidemiol. 2003;157(10):906\u201314. https:\/\/doi.org\/10.1093\/aje\/kwg051.","journal-title":"Am J Epidemiol"},{"issue":"10","key":"1346_CR40","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1002\/ijc.21668","volume":"118","author":"LD Maso","year":"2006","unstructured":"Maso LD, Zucchetto A, Tavani A, Montella M, Ramazzotti V, Polesel J, et al. Lifetime occupational and recreational physical activity and risk of benign prostatic hyperplasia. Int J Cancer. 2006;118(10):2632\u20135. https:\/\/doi.org\/10.1002\/ijc.21668.","journal-title":"Int J Cancer"},{"issue":"4","key":"1346_CR41","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/01.ede.0000219723.14476.28","volume":"17","author":"S Rohrmann","year":"2006","unstructured":"Rohrmann S, Fallin MD, Page WF, Reed T, Partin AW, Walsh PC, et al. Concordance Rates and Modifiable Risk Factors for Lower Urinary Tract Symptoms in Twins. Epidemiology. 2006;17(4):419\u201327.","journal-title":"Epidemiology"},{"issue":"10","key":"1346_CR42","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.puhe.2007.01.011","volume":"121","author":"L Fritschi","year":"2007","unstructured":"Fritschi L, Tabrizi J, Leavy J, Ambrosini G, Timperio A. Risk factors for surgically treated benign prostatic hyperplasia in Western Australia. Public Health (Lond). 2007;121(10):781\u20139. https:\/\/doi.org\/10.1016\/j.puhe.2007.01.011.","journal-title":"Public Health (Lond)"},{"key":"1346_CR43","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.21.2349","author":"EA Platz","year":"1998","unstructured":"Platz EA, Kawachi I, Rimm EB, Colditz GA, Stampfer MJ, Willett WC, et al. Physical activity and benign prostatic hyperplasia. Arch Intern Med. 1998. https:\/\/doi.org\/10.1001\/archinte.158.21.2349.","journal-title":"Arch Intern Med"},{"issue":"9","key":"1346_CR44","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/S0895-4356(01)00351-1","volume":"54","author":"JB Meigs","year":"2001","unstructured":"Meigs JB, Mohr B, Barry MJ, Collins MM, McKinlay JB. Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol. 2001;54(9):935\u201344. https:\/\/doi.org\/10.1016\/S0895-4356(01)00351-1.","journal-title":"J Clin Epidemiol"},{"issue":"Suppl 1","key":"1346_CR45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000049871","volume":"40","author":"D Prezioso","year":"2001","unstructured":"Prezioso D, Catuogno C, Galassi P, D\u2019Andrea G, Castello G, Pirritano D. Life-Style in Patients with LUTS Suggestive of BPH. Eur Urol. 2001;40(Suppl 1):9\u201312. https:\/\/doi.org\/10.1159\/000049871.","journal-title":"Eur Urol"},{"issue":"3","key":"1346_CR46","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1249\/MSS.0000000000000444","volume":"47","author":"KY Wolin","year":"2015","unstructured":"Wolin KY, Grubb RL, Pakpahan R, Ragard L, Mabie J, Andriole GL, et al. Physical activity and benign prostatic hyperplasia-related outcomes and nocturia. Med Sci Sports Exerc. 2015;47(3):581\u201392. https:\/\/doi.org\/10.1249\/MSS.0000000000000444.","journal-title":"Med Sci Sports Exerc"},{"issue":"4","key":"1346_CR47","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s11255-008-9338-7","volume":"40","author":"MR Safarinejad","year":"2008","unstructured":"Safarinejad MR. Prevalence of benign prostatic hyperplasia in a population-based study in Iranian men 40 years old or older. Int Urol Nephrol. 2008;40(4):921\u201331. https:\/\/doi.org\/10.1007\/s11255-008-9338-7.","journal-title":"Int Urol Nephrol"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-026-01346-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11934-026-01346-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-026-01346-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T03:56:13Z","timestamp":1784606173000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11934-026-01346-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1346"],"URL":"https:\/\/doi.org\/10.1007\/s11934-026-01346-z","relation":{},"ISSN":["1534-6285"],"issn-type":[{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"25 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"33"}}